Asprosin, a novel pleiotropic adipokine implicated in fasting and obesity-related cardio-metabolic disease: Comprehensive review of preclinical and clinical evidence
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Asprosin, a novel pleiotropic adipokine implicated in fasting and obesity-related cardio-metabolic disease: Comprehensive review of preclinical and clinical evidence
Authors
Keywords
Adipokines, Adipose tissue, Asprosin, Diabetes, Inflammation, Metabolism, Obesity
Journal
CYTOKINE & GROWTH FACTOR REVIEWS
Volume 60, Issue -, Pages 120-132
Publisher
Elsevier BV
Online
2021-05-28
DOI
10.1016/j.cytogfr.2021.05.002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High Serum Asprosin Levels Are Associated with Presence of Metabolic Syndrome
- (2021) Tao Hong et al. International Journal of Endocrinology
- Effect of sodium–glucose co-transporter-2 inhibitors on the levels of serum asprosin in patients with newly diagnosed type 2 diabetes mellitus
- (2021) Aijun Jiang et al. Diabetology & Metabolic Syndrome
- Asprosin serum levels and glucose homeostasis in children with obesity
- (2021) Domenico Corica et al. CYTOKINE
- An MRM-Based Multiplexed Quantification Assay for Human Adipokines and Apolipoproteins
- (2020) Laura Krieg et al. MOLECULES
- Increased Serum Circulating Asprosin Levels in Children with Obesity
- (2020) Eda Sünnetçi Silistre et al. PEDIATRICS INTERNATIONAL
- Continuous elevation of plasma asprosin in pregnant women complicated with gestational diabetes mellitus: A nested case-control study
- (2020) Lieqiang Zhong et al. PLACENTA
- The Asprosin–OLFR734 module regulates appetitive behaviors
- (2020) Yang Liu et al. Cell Discovery
- Adipokines as novel biomarkers of cardio-metabolic disorders
- (2020) Xin Su et al. CLINICA CHIMICA ACTA
- Serum concentration of asprosin in new-onset type 2 diabetes
- (2020) Shakiba Naiemian et al. Diabetology & Metabolic Syndrome
- The Role of Exercise in the Interplay between Myokines, Hepatokines, Osteokines, Adipokines, and Modulation of Inflammation for Energy Substrate Redistribution and Fat Mass Loss: A Review
- (2020) Adrian M. Gonzalez-Gil et al. Nutrients
- The role of Asprosin in patients with dilated cardiomyopathy
- (2020) Ming-Shien Wen et al. BMC Cardiovascular Disorders
- Assessment of acute aerobic exercise in the morning versus evening on asprosin, spexin, lipocalin-2, and insulin level in overweight/obese versus normal weight adult men
- (2020) Halil İbrahim Ceylan et al. CHRONOBIOLOGY INTERNATIONAL
- Combination of asprosin and adiponectin as a novel marker for diagnosing non-alcoholic fatty liver disease
- (2020) Fan Ke et al. CYTOKINE
- Newly Discovered Adipokines: Pathophysiological Link Between Obesity and Cardiometabolic Disorders
- (2020) Jung A. Kim et al. Frontiers in Physiology
- Expression and purification of asprosin in Pichia pastoris and investigation of its increase glucose uptake activity in skeletal muscle through activation of AMPK
- (2020) Yunhua Zhang et al. ENZYME AND MICROBIAL TECHNOLOGY
- The Distinct Effects of Palmitic and Oleic Acid on Pancreatic Beta Cell Function: The Elucidation of Associated Mechanisms and Effector Molecules
- (2019) Miruna Nemecz et al. Frontiers in Pharmacology
- The obesity transition: stages of the global epidemic
- (2019) Lindsay M Jaacks et al. Lancet Diabetes & Endocrinology
- Saliva and Blood Asprosin Hormone Concentration Associated with Obesity
- (2019) Kader Ugur et al. International Journal of Endocrinology
- Obesity: global epidemiology and pathogenesis
- (2019) Matthias Blüher Nature Reviews Endocrinology
- Asprosin attenuates insulin signaling pathway through PKCδ‐activated ER stress and inflammation in skeletal muscle
- (2019) Tae Woo Jung et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Asprosin impairs insulin secretion in response to glucose and viability through TLR4/JNK-mediated inflammation
- (2019) Taeseung Lee et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients
- (2019) Chia Lin Chang et al. Scientific Reports
- OLFR734 Mediates Glucose Metabolism as a Receptor of Asprosin
- (2019) Erwei Li et al. Cell Metabolism
- Decreased Circulating Levels of Asprosin in Obese Children
- (2019) Wenjun Long et al. Hormone Research in Paediatrics
- The endocrine function of adipose tissues in health and cardiometabolic disease
- (2019) Ludger Scheja et al. Nature Reviews Endocrinology
- Asprosin improves the survival of mesenchymal stromal cells in myocardial infarction by inhibiting apoptosis via the activated ERK1/2-SOD2 pathway
- (2019) Zhengbin Zhang et al. LIFE SCIENCES
- Sense of Smell as the Central Driver of Pavlovian Appetite Behavior in Mammals
- (2019) Leon G. Fine et al. Frontiers in Physiology
- Decreased Blood Asprosin in Hyperglycemic Menopausal Women as a Result of Whole-Body Cryotherapy Regardless of Metabolic Syndrome
- (2019) Magdalena Wiecek et al. Journal of Clinical Medicine
- Asprosin in umbilical cord of newborns and maternal blood of gestational diabetes, preeclampsia, severe preeclampsia, intrauterine growth retardation and macrosemic fetus
- (2019) Yakup Baykus et al. PEPTIDES
- Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus
- (2019) Xinyue Zhang et al. Journal of Diabetes Investigation
- The Asprosin-OLFR734 hormonal signaling axis modulates male fertility
- (2019) Fangchao Wei et al. Cell Discovery
- Regulation of Hepatic Glucose Production by Transforming Growth Factor Beta 1 via Protein Kinase A
- (2018) QUAN PAN et al. DIABETES
- Plasma Asprosin Concentrations Are Increased in Individuals with Glucose Dysregulation and Correlated with Insulin Resistance and First-Phase Insulin Secretion
- (2018) Yuren Wang et al. MEDIATORS OF INFLAMMATION
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- The epidemiology of obesity
- (2018) Yu Chung Chooi et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Serum asprosin levels and bariatric surgery outcomes in obese adults
- (2018) Chao-Yung Wang et al. INTERNATIONAL JOURNAL OF OBESITY
- Plasma Asprosin Levels Are Associated with Glucose Metabolism, Lipid, and Sex Hormone Profiles in Females with Metabolic-Related Diseases
- (2018) Xing Li et al. MEDIATORS OF INFLAMMATION
- Acute Anaerobic Exercise Affects the Secretion of Asprosin, Irisin, and Other Cytokines – A Comparison Between Sexes
- (2018) Magdalena Wiecek et al. Frontiers in Physiology
- Skeletal muscle inflammation and insulin resistance in obesity
- (2017) Huaizhu Wu et al. JOURNAL OF CLINICAL INVESTIGATION
- Adiponectin improves insulin sensitivity via activation of autophagic flux
- (2017) Penny Ahlstrom et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Asprosin is a centrally acting orexigenic hormone
- (2017) Clemens Duerrschmid et al. NATURE MEDICINE
- A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus
- (2017) A. Avogaro et al. Expert Review of Clinical Pharmacology
- Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride
- (2017) Lei Zhang et al. CLINICA CHIMICA ACTA
- Asprosin, a Fasting-Induced Glucogenic Protein Hormone
- (2016) Chase Romere et al. CELL
- The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited
- (2016) Robert L. Rosenfield et al. ENDOCRINE REVIEWS
- The Adipokine-Cardiovascular-Lifestyle Network
- (2016) Jeffrey I. Mechanick et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Expression of FBN1 during adipogenesis: Relevance to the lipodystrophy phenotype in Marfan syndrome and related conditions
- (2016) Margaret R. Davis et al. MOLECULAR GENETICS AND METABOLISM
- Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders
- (2016) Sung Sik Choe et al. Frontiers in Endocrinology
- Role of PKCδ in Insulin Sensitivity and Skeletal Muscle Metabolism
- (2015) Mengyao Li et al. DIABETES
- Body Composition, Lipid Profile, Adipokine Concentration, and Antioxidant Capacity Changes during Interventions to Treat Overweight with Exercise Programme and Whole-Body Cryostimulation
- (2015) Anna Lubkowska et al. Oxidative Medicine and Cellular Longevity
- Neonatal progeroid variant of Marfan syndrome with congenital lipodystrophy results from mutations at the 3′ end of FBN1 gene
- (2014) Adeline Jacquinet et al. European Journal of Medical Genetics
- Low Concentrations of Metformin Suppress Glucose Production in Hepatocytes through AMP-activated Protein Kinase (AMPK)
- (2014) Jia Cao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Exercise Induced Adipokine Changes and the Metabolic Syndrome
- (2014) Saeid Golbidi et al. Journal of Diabetes Research
- Adipokines in gestational diabetes
- (2014) Mathias Fasshauer et al. Lancet Diabetes & Endocrinology
- Severe congenital lipodystrophy and a progeroid appearance: Mutation in the penultimate exon ofFBN1causing a recognizable phenotype
- (2013) Toshiki Takenouchi et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Whole-body cryostimulation as an effective method of reducing low-grade inflammation in obese men
- (2013) Ewa Ziemann et al. Journal of Physiological Sciences
- Increased systemic and adipose tissue inflammation differentiates obese women with T2DM from obese women with normal glucose tolerance
- (2013) Lianne van Beek et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Further evidence for a marfanoid syndrome with neonatal progeroid features and severe generalized lipodystrophy due to frameshift mutations near the 3′ end of the FBN1 gene
- (2011) Jack Goldblatt et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Marfan syndrome with neonatal progeroid syndrome-like lipodystrophy associated with a novel frameshift mutation at the 3′ terminus of the FBN1-gene
- (2010) Luitgard M. Graul-Neumann et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Dilated cardiomyopathy
- (2010) John Lynn Jefferies et al. LANCET
- Fatty liver and lipotoxicity
- (2009) Michael Trauner et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- The pathogenesis of diabetic nephropathy
- (2008) Suma Dronavalli et al. Nature clinical practice. Endocrinology & metabolism
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started